Schering's diagnostic sales down 6%:
This article was originally published in Clinica
Executive Summary
German company Schering's contrast media sales fell 6% to DM 1,194 million ($838 million) in the first nine months of 1995. The company blames the strong mark together with the withdrawal of its contrast medium, Isovist 280 (see Clinica No 675, p 9). Schering feels that although sales will be lost through the product withdrawal, this may be partially offset by increased sales of other Schering contrast agents. Net profits were down 18% to DM 172 million and total group sales fell 2% to DM 3,499 million. Analysts predict that on current sales performance and forecasts, results for 1996 will not improve on those for 1994.